Diets with a high ratio of omega-6 to omega-3 fatty acids are linked to higher levels of inflammation and greater body fat in humans, while diets with a balanced ratio are linked to lower...
Mechanism
Synthesis from 1 study
Eating too much omega-6 and too little omega-3 causes your cells to produce chemicals that trigger inflammation and make more fat cells. Omega-3 fats block these effects by competing with omega-6 fats and making anti-inflammatory signals instead. This imbalance directly drives weight gain and...
Most probable mechanism
When people eat a lot of omega-6 fats and very little omega-3, their cells fill up with a fatty acid called arachidonic acid. This triggers the production of strong inflammatory chemicals that cause swelling and tissue damage. At the same time, these fats activate pathways that turn fat cells into more fat cells and increase hunger, leading to weight gain. Omega-3 fats block these effects by competing with arachidonic acid and producing anti-inflammatory signals instead.
Dietary linoleic acid (ω-6) is absorbed and converted into arachidonic acid through desaturation and elongation in the liver and adipose tissue
Arachidonic acid is incorporated into cell membrane phospholipids in immune cells, adipocytes, and hepatocytes
Inflammatory stimuli activate phospholipase A2, releasing arachidonic acid from membrane phospholipids
Free arachidonic acid is metabolized by cyclooxygenase and lipoxygenase enzymes into pro-inflammatory prostaglandins and leukotrienes
Arachidonic acid is also converted into prostacyclin, which activates PPARγ and increases cAMP/PKA signaling to drive adipocyte differentiation and lipid storage
Arachidonic acid is used to synthesize endocannabinoids anandamide and 2-AG, which activate CB1 receptors in the hypothalamus and adipose tissue to increase appetite and lipogenesis
Dietary ω-3 fatty acids (EPA and DHA) displace arachidonic acid from membrane phospholipids and compete for the same metabolic enzymes
EPA and DHA are metabolized into resolvins, protectins, and maresins that suppress neutrophil infiltration, reduce cytokine production, and actively resolve inflammation
EPA and DHA inhibit prostacyclin and endocannabinoid synthesis, reducing adipogenesis and food intake
Genetic variants in FADS1 reduce the conversion of linoleic acid to arachidonic acid and alpha-linolenic acid to EPA/DHA, leading to accumulation of linoleic acid and altered membrane composition that promotes adipose inflammation under high ω-6 intake
Less supported by current evidence, but not ruled out
Certain gut bacteria can transform omega-6 linoleic acid into a compound called HYA, which triggers the release of a hormone that reduces hunger and blocks fat absorption in the intestine, counteracting obesity.
Dietary linoleic acid reaches the small intestine and interacts with commensal Lactobacillus species expressing conjugated linoleic acid-oleate hydratase
Lactobacillus converts linoleic acid into 10-hydroxy-cis-12-octadecenoic acid (HYA)
HYA activates GPR40 and GPR120 receptors on intestinal L-cells to stimulate glucagon-like peptide-1 (GLP-1) secretion
GLP-1 enhances insulin sensitivity, suppresses appetite, and slows gastric emptying
HYA activates EP3 receptors to inhibit lipid absorption and promote intestinal peristalsis
Evidence from Studies
Supporting (1)
Community contributions welcome
ω-6 and ω-3 Polyunsaturated Fatty Acids: Inflammation, Obesity and Foods of Animal Resources
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.